Abstracts Archive - Page 1112 of 2425 - ACR Meeting Abstracts

Abstract Number: 1611 • 2018 ACR/ARHP Annual Meeting
Hospitalizations for Serious Infections in Psoriatic Arthritis Patients: Data from the National Inpatient Sample 2000-2014
Paras Karmacharya¹, Cynthia S. Crowson², Dilli Poudel³, Pragya Shrestha⁴ and Kerry Wright⁵, ¹Division of Rheumatology, Mayo Clinic, Rochester, MN, ²Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, ³Internal Medicine, Reading Hospital-Tower Health System, WEST READING, PA, ⁴Internal medicine, Reading Hospital-Tower Health System, West Reading, PA, ⁵Rheumatology, Mayo Clinic, Rochester, MN
Background/Purpose: Increased risk of infections has been recognized in patients with psoriatic arthritis (PsA) compared to those without PsA. Immunomodulatory effects of PsA, immunosuppressive therapies…
Abstract Number: 1612 • 2018 ACR/ARHP Annual Meeting
Myocardial Infarctions Among Ankylosing Spondylitis Patients in a Large US Insurance Database
Maureen Dubreuil¹, Christine Peloquin², David T. Felson³ and Tuhina Neogi³, ¹Clinical Epidemiology and Rheumatology, Boston University School of Medicine, Boston, MA, ²Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, ³Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA
Background/Purpose: Risk of myocardial infarction (MI) is estimated to be increased up to 60% in ankylosing spondylitis (AS). Studies in patients with rheumatoid arthritis, psoriatic…
Abstract Number: 1613 • 2018 ACR/ARHP Annual Meeting
Dactylitis in Early Spondyloarthritis. Baseline Data from a Prospective French National Cohort
Daniel Wendling¹, Clément Prati², Alain Saraux³, Anna Molto⁴, Thao Pham⁵, Maxime Dougados⁶ and Xavier Guillot⁷, ¹Rheumatology, University Hospital - Bourgogne Franche Comté University, Besançon, France, ²Rheumatology, University Hospital - Bourgogne Franche Comté University, Besancon, France, ³Rheumatology, CHU Brest, Brest, France, ⁴Hôpital Cochin, Department of Rheumatology, Paris Descartes University, Paris, France, ⁵Rheumatology Department, Aix-Marseille University, APHM, Marseille, France, ⁶Department of Rheumatology, Paris Descartes University and Cochin Hospital, Paris, France, ⁷PEPITE EA 4267, Bourgogne-Franche-Comté university, Besançon, France
Background/Purpose: Dactylitis is a particular feature shared across the several phenotypical forms of spondyloarthritis (SpA), part of the classification criteria. There are only few data…
Abstract Number: 1614 • 2018 ACR/ARHP Annual Meeting
Prevalence of Sonographic Enthesitis in Patients with Psoriasis without Arthritis and Its Association Risk Factors of Psoriatic Arthritis
Anwar Albasri¹, Justine Y. Ye², Cheryl F. Rosen³, Vinod Chandran², Dafna D Gladman⁴ and Lihi Eder⁵, ¹Rheumatology, University of Toronto, Toronto, ON, Canada, ²Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ³University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁴Department of Medicine, Toronto Psoriatic Arthritis Research Program, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁵Women's College Research Institute, University of Toronto, Women's College Hospital, Toronto, ON, Canada
Background/Purpose: Enthesitis is one of the hallmarks of psoriatic arthritis (PsA) and may be the initial site of musculoskeletal inflammation. Enthesitis affects up to 50…
Abstract Number: 1615 • 2018 ACR/ARHP Annual Meeting
Comparative Risk of Atrial Fibrillation and Cardiovascular Events between TNF-Inhibitors and Ustekinumab in Patients with Psoriasis and Psoriatic Arthritis: A Population-Based Multi-Database Study
Moa Lee¹, Rishi J. Desai², Yinzhu Jin³, Gregory Brill¹, Alexis Ogdie⁴ and Seoyoung C. Kim¹, ¹Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ²Division of Pharmacoepidemiology and Pharmacoeconimics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ³Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ⁴Medicine/Rheumatology and Epidemiology, University of Pennsylvania, Philadelphia, PA
Background/Purpose: Cardiovascular disease is a major comorbidity in patients with psoriasis (PsO) and psoriatic arthritis (PsA). Increasing evidence suggests a potential reduction in the risk…
Abstract Number: 1616 • 2018 ACR/ARHP Annual Meeting
Region-Specific Differences in Clinical Presentation of Patients with Axial Spondyloarthritis – Results from a Large Multinational Cohort Study
Denis Poddubnyy¹, Robert D Inman², Joachim Sieper¹, Fabiana Ganz³ and Maja Hojnik⁴, ¹Charité Universitätsmeidzin Berlin, Berlin, Germany, ²Department of Medicine, University of Toronto, Toronto, ON, Canada, ³AbbVie, Baar, Switzerland, ⁴AbbVie, Ljubljana, Slovenia
Background/Purpose: There is limited evidence on the phenotypic characteristics of axial spondyloarthritis (axSpA) patients (pts) in various geographic regions around the world. This analysis aimed…
Abstract Number: 1617 • 2018 ACR/ARHP Annual Meeting
Influence of Disease Activity in the Physical Activity of Psoriatic Arthritis Patients
M. Vanesa Hernandez-Hernandez¹, Hiurma Sanchez-Perez², Esmeralda Delgado-Frías¹, Iván Ferraz-Amaro³ and Federico Díaz-González⁴, ¹Rheumatology Division, Hospital Universitario de Canarias, La Laguna, Spain, ²Rheumatology, Rheumatology Division, Hospital Universitario de Canarias, La Laguna, Spain, ³Rheumatology Division, Hospital Insular de Gran Canaria, La Laguna, Spain, ⁴University of La Laguna, Hospital Universitario de Canarias, La Laguna, Spain
Background/Purpose: It is generally assumed that patients with chronic arthritis conditions tend to exercise less than what is currently recommended. Although several evidences support this…
Abstract Number: 1618 • 2018 ACR/ARHP Annual Meeting
Adipose Tissue Inflammation in Psoriatic Arthritis: Overexpression of a Wide Array of Inflammatory Mediators and Associations with Disease and Treatment Characteristics
Jae Hee Yun¹, Robert Winchester², Hui-Zhu Zhang², Christopher Depender¹ and Jon T. Giles¹, ¹Medicine/Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, ²Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY
Background/Purpose: Obesity is associated with PsA risk, severity, and lack of response to DMARDs. However, no studies have explored adipose tissue inflammation at the molecular…
Abstract Number: 1619 • 2018 ACR/ARHP Annual Meeting
Patterns and Outcomes on As Patients Disease Activity Using Smart System of Disease Management (SSDM): Analysis of T2T Pattern Shift and the Correlation between Disease Activity and Mental Health
Jing Xue¹, Hui Song², Jing Yang³, Zhenchun Zhang⁴, Chun Li⁵, Hongbin Li⁶, Zhenbiao Wu⁷, Hua Wei⁸, Jianlin Huang⁹, Hongzhi Wang¹⁰, Yasong Li¹¹, Xiaohan Wang¹², Henglian Wu¹³, Miaojia Zhang¹⁴, Yuhua Jia¹⁵, Hui Xiao¹⁵, Fei Xiao¹⁵ and Huaxiang Wu¹⁶, ¹88 Jiefang Road, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China, ²Department of Rheumatology, Beijing Jishuitan Hospital, Beijing, China, ³Department of rheumatology, Central Hospital of MianYang, Sichuan, Mian Yang, China, ⁴People's Hospital of Linyi, Shandong, Linyi, China, ⁵Peking University People's Hospital, Beijing, China, ⁶The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China, ⁷The First Affiliated Hospital of The Fourth Military Medical University, Xi'an, China, ⁸Northern Jiangsu People's Hospital, Yangzhou, China, ⁹Department of rheumatology, The Sixth Hospital Affiliated to Sun yat-sen University, Guangzhou, China, ¹⁰The First Hospital of Jiaxing, Jiaxing, China, ¹¹Department of Rheumatology and Immunology, Zhejiang Provincal People's Hospital, Hangzhou, China, ¹²Department of Rheumatology and Immunology, Anyang district hospital, Anyang, China, ¹³Dongguan Donghua Hospital, Dongguan, China, ¹⁴Department of Rheumatology and Immunology, Jiangsu Province Hospital, Nanjing, China, ¹⁵Shanghai Gothic Internet Technology Co., Ltd., Shanghai, China, ¹⁶The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
Background/Purpose: Ankylosing Spondylitis Disease Activity Score (ASDAS) was adopted to evaluate the degree of disease activity and the inflammatory response in AS patients. ASDAS score…
Abstract Number: 1620 • 2018 ACR/ARHP Annual Meeting
Lateral DXA More Effective in Detecting Osteoporosis Than Conventional DXA in Axial Spondyloarthropathy
Gillian Fitzgerald^1,2, Jason Wyse³, Tochukwu Anachebe⁴, Ronan Mullan⁵, David Kane⁶, Kevin McCarroll⁷ and Finbar O' Shea², ¹School of Medicine, Trinity College Dublin, Dublin 2, Ireland, ²Rheumatology, St. James's Hospital, Dublin 8, Ireland, ³School of Computer Science and Statistics, Trinity College Dublin, Dublin 2, Ireland, ⁴Department of Rheumatology, St. James's Hospital, Dublin 8, Ireland, ⁵Department of Rheumatology,, Tallaght Hospital, Dublin, Ireland, ⁶Department of Rheumatology, Tallaght Hospital, TCD, Dublin 24, Ireland, ⁷Department of Medicine for the Elderly, St. James's Hospital, Dublin 8, Ireland
Background/Purpose: The severe consequences of osteoporosis in the general population are well outlined. In axial spondyloarthropathy (axSpA), osteoproliferation of the spine means posterioanterior (PA) dual-energy…
Abstract Number: 1621 • 2018 ACR/ARHP Annual Meeting
Higher Serum Uric Acid Levels Protect Against Osteoporosis in Patients with Axial Spondyloarthropathy
Gillian Fitzgerald^1,2, Tochukwu Anachebe³, Ronan Mullan⁴, David Kane⁵, Kevin McCarroll⁶ and Finbar O' Shea², ¹School of Medicine, Trinity College Dublin, Dublin 2, Ireland, ²Rheumatology, St. James's Hospital, Dublin 8, Ireland, ³Department of Rheumatology, St. James's Hospital, Dublin 8, Ireland, ⁴Department of Rheumatology,, Tallaght Hospital, Dublin, Ireland, ⁵Department of Rheumatology, Tallaght Hospital, Dublin 24, Ireland, ⁶Department of Medicine for the Elderly, St. James's Hospital, Dublin 8, Ireland
Background/Purpose: High serum urate (SUA) is a risk factor for metabolic disease, including hypertension and coronary artery disease. However, SUA has an antioxidant effect and…
Abstract Number: 1622 • 2018 ACR/ARHP Annual Meeting
ASAS Consensus on Spanish Nomenclature for Spondyloarthritis
Victoria Navarro-Compán¹, Teresa Oton-Sanchez², Estibaliz Loza³, Raquel Almodóvar González⁴, Rafael Ariza⁵, Wilson Bautista-Molano⁶, Rubén Burgos-Vargas⁷, Eduardo Collantes Estevez⁸, Eugenio De Miguel⁹, Carlos M Gonzalez¹⁰, Jordi Gratacos-Masmitja¹¹, Sebastián Ibáñez¹², Xavier Juanola¹³, José A. Maldonado-Cocco¹⁴, Anna Molto¹⁵, Juan D. Mulero¹⁶, Cesar Pacheco-Tena¹⁷, Cesar Ramos-Remus¹⁸, Jesus Sanz¹⁹, Rafael Valle-Oñate²⁰, Pedro Zarco²¹ and Helena Marzo-Ortega²², ¹Immuno-Rheumatology research group, IdiPaz. La Paz University Hospital, Madrid, Spain, ²InMusc. Instituto de Salud Músculo-Esquelética, Madrid, Spain, ³INMUSC, Instituto de Salud Musculoesquelética (InMusc), Madrid, Spain, ⁴Rheumatology, Hospital Universitario Fundación Alcorcón. Madrid. Spain, Madrid, Spain, ⁵Rheumatology, Hospital Universitario Virgen Macarena, Sevilla, Spain, ⁶Hospital Militar, Bogotá, Colombia, ⁷Department of Rheumatology, Hospital General de México "Dr. Eduardo Liceaga", Mexico City, Mexico, ⁸IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, ⁹Rheumatology, University Hospital La Paz, IdiPaz, Madrid, Spain, ¹⁰Servicio de Reumatología, Hospital General Universitario Gregorio Marañón, Madrid, Spain, ¹¹Rheumatology, Hospital Parc Taulí, Sabadell - Barcelona, Spain, ¹²Rheumatology Department, Clínica Alemana de Santiago, Santiago, Chile, ¹³Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, ¹⁴Buenos Aires University, Consulting Professor of Rheumatology, Buenos Aires University. Argentina, Buenos Aires, Argentina, ¹⁵Hôpital Cochin, Department of Rheumatology, Paris Descartes University, Paris, France, ¹⁶Hospital Puerta de Hierro, Majadahonda, Madrid, Spain, ¹⁷Universidad Autónoma de Chihuahua, Hospital Christus Muguerza del Parque, Chihuahua, Mexico, ¹⁸Universidad Autonoma de Guadalajara, Zapopan, Mexico, ¹⁹Rheumatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain, ²⁰Unidad de Reumatologia, Hospital Militar, Bogota, Colombia, ²¹H Fundación Alcorcón, Alcorcón, Spain, ²²NIHR LBRC, LTHT and LIRMM, UoL, Leeds, United Kingdom
Background/Purpose: In the last three decades, major advances in the spondyloarthritis (SpA) field have been achieved leading to new terminology. Whilst this terminology is well…
Abstract Number: 1623 • 2018 ACR/ARHP Annual Meeting
Insight into the Quality of Life of Patients with Ankylosing Spondylitis: Real-World Data from a US-Based Life Impact Survey
James T. Rosenbaum¹, Lisa Pisenti², Yujin Park³ and Richard Howard⁴, ¹Ophthalmology, Oregon Health & Science University and Legacy Devers Eye Institute, Portland, OR, ²UCB, Inc., Smyrna, GA, ³Novartis Pharmaceuticals Corporation, East Hanover, NJ, ⁴Spondylitis Association of America, Van Nuys, CA
Background/Purpose: While severe pain and stiffness are common hallmarks of ankylosing spondylitis (AS), disease progression is slow and not always visible; however, the quality of…
Abstract Number: 1624 • 2018 ACR/ARHP Annual Meeting
Real-World Insight into the Disease Burden and Treatment of Spondyloarthritis from a US-Based Life Impact Survey
James T. Rosenbaum¹, Lisa Pisenti², Yujin Park³ and Richard Howard⁴, ¹Ophthalmology, Oregon Health & Science University and Legacy Devers Eye Institute, Portland, OR, ²UCB, Inc., Smyrna, GA, ³Novartis Pharmaceuticals Corporation, East Hanover, NJ, ⁴Spondylitis Association of America, Van Nuys, CA
Background/Purpose: Spondyloarthritis (SpA) is a group of chronic, inflammatory diseases associated with severe pain in the joints and entheses. There is limited evidence on real-world…
Abstract Number: 1625 • 2018 ACR/ARHP Annual Meeting
Association of HLA-B Type and Sacroiliitis in Patients with Psoriatic Arthritis
Daniel Kuo¹, Isela Valera², Mihaela Taylor¹, Roy Altman¹, Veena K. Ranganath¹, Thanda Aung¹, James Louie¹ and Suzanne Kafaja¹, ¹Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA, ²Autoimmunity and Tolerance Laboratory, Division of Rheumatology, Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA
Background/Purpose: Psoriatic arthritis (PsA) is a heterogeneous disease with strong genetic heritability. Class I major histocompatibility complex (MHC) genes have been associated with PsA phenotype…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].